Project: Super Biased Ligands for Treatment of Type II Diabetes

We have very exciting results showing that we can develop compounds, “super biased ligands”, that simultaneously stimulate glucose uptake in muscle and brown fat through a novel insulin independent signalling pathway. The compounds radically reduce blood glucose levels in rodent diabetes models and our goal is to develop them to a preCD for the treatment of type 2 diabetes and forge a business alliance with a pharmaceutical company.

Acronym	SUBERB (Reference Number: 10635)
Duration	01/09/2016 - 01/09/2019
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 5

Project partner

Number	Name	Role	Country
24745	Atrogi AB	Coordinator	Sweden
24746	Maastricht University	Partner	Netherlands
24747	Stockholms Universitet	Partner	Sweden
24748	Latvia Institute for Organic Synthesis	Partner	Latvia